Rhythm Pharmaceuticals Inc (RYTM)
SG&A Expense Growth
35.09%
Fiscal year · Period ending:
RYTM SG&A Expense Growth
Latest reported35.09%period ending
Latest reported35.09%period ending
RYTM FY SG&A Growth (YoY) (0.00% → 35.09%)
Latest values, visible window
High-resolution chart · PNG
RYTM sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 35.0905% | |
| 22.7785% | |
| 27.7078% | |
| 34.3807% | |
| 48.4791% | |
| 26.197% | |
| 30.1638% | |
| 195.02% | |
| 50.816% | |
| 84.2628% | |
| 182.3578% | |
| -64.6665% | |
| 39.5528% | |
| 0% |